ES2551697T3 - Protección de péptidos contra toxicidad por luz ultravioleta - Google Patents

Protección de péptidos contra toxicidad por luz ultravioleta Download PDF

Info

Publication number
ES2551697T3
ES2551697T3 ES10832158.9T ES10832158T ES2551697T3 ES 2551697 T3 ES2551697 T3 ES 2551697T3 ES 10832158 T ES10832158 T ES 10832158T ES 2551697 T3 ES2551697 T3 ES 2551697T3
Authority
ES
Spain
Prior art keywords
protection
ultraviolet light
peptides against
against toxicity
toxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10832158.9T
Other languages
English (en)
Inventor
Lijuan Zhang
Timothy J. Falla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helix Biomedix Inc
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Application granted granted Critical
Publication of ES2551697T3 publication Critical patent/ES2551697T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un péptido compuesto por la secuencia de las SEC ID Nº 3, 5, 6, 8 o 10.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11

Claims (1)

  1. imagen1
ES10832158.9T 2009-11-19 2010-11-18 Protección de péptidos contra toxicidad por luz ultravioleta Active ES2551697T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26279009P 2009-11-19 2009-11-19
US262790P 2009-11-19
PCT/US2010/057177 WO2011063090A2 (en) 2009-11-19 2010-11-18 Peptide protection against ultraviolet light toxicity

Publications (1)

Publication Number Publication Date
ES2551697T3 true ES2551697T3 (es) 2015-11-23

Family

ID=44060329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10832158.9T Active ES2551697T3 (es) 2009-11-19 2010-11-18 Protección de péptidos contra toxicidad por luz ultravioleta

Country Status (12)

Country Link
US (1) US8597902B2 (es)
EP (1) EP2512498B1 (es)
KR (1) KR101764171B1 (es)
CN (1) CN102791281B (es)
CA (1) CA2779863C (es)
ES (1) ES2551697T3 (es)
PL (1) PL2512498T3 (es)
RU (1) RU2565535C2 (es)
SM (1) SMT201500305B (es)
TW (1) TWI494129B (es)
WO (1) WO2011063090A2 (es)
ZA (1) ZA201203397B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI698249B (zh) * 2018-12-27 2020-07-11 三凡生技研發股份有限公司 短鏈胜肽組合物於保護眼睛抗光害之應用
CN112535733A (zh) * 2020-12-04 2021-03-23 中南大学湘雅三医院 tRFs在UV辐射致皮肤急性损伤的产品中的应用
CN113683662B (zh) * 2021-03-05 2022-11-04 四川大学 一种防护紫外皮肤损伤的多肽
CN114569702B (zh) * 2022-03-07 2022-10-18 上海揽微赛尔生物科技有限公司 含有抗衰老活性肽与干细胞的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0939829B1 (en) 1996-03-28 2008-08-20 Trustees Of Boston University Methods of modulating melanin synthesis
JP2008509157A (ja) 2004-08-06 2008-03-27 ソフェリオン セラピューティクス，インコーポレイテッド 抗血管新生ペプチドおよびその使用方法
EP2144935A2 (en) * 2007-03-29 2010-01-20 Technion Research & Development Foundation Ltd. Antibodies, methods and kits for diagnosing and treating melanoma

Also Published As

Publication number Publication date
RU2565535C2 (ru) 2015-10-20
EP2512498B1 (en) 2015-09-16
KR101764171B1 (ko) 2017-08-02
CA2779863A1 (en) 2011-05-26
EP2512498A4 (en) 2013-06-05
PL2512498T3 (pl) 2016-03-31
CN102791281B (zh) 2014-12-17
HK1170419A1 (en) 2013-03-01
TW201138851A (en) 2011-11-16
US8597902B2 (en) 2013-12-03
ZA201203397B (en) 2013-08-28
WO2011063090A3 (en) 2011-08-18
TWI494129B (zh) 2015-08-01
SMT201500305B (it) 2016-01-08
CN102791281A (zh) 2012-11-21
US20120225023A1 (en) 2012-09-06
EP2512498A2 (en) 2012-10-24
RU2012125260A (ru) 2013-12-27
KR20120116926A (ko) 2012-10-23
WO2011063090A2 (en) 2011-05-26
CA2779863C (en) 2020-07-21

Similar Documents

Publication Publication Date Title
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
ES2512141T3 (es) Análogo peptídico de oxintomodulina
ES2486675T3 (es) Análogo de péptido de oxintomodulina
EP2118122A4 (en) NOVEL ANTIMICROBIAL PEPTIDES
UA118167C2 (uk) Пептид та його застосування
ES2666720T3 (es) Composición para prevenir o tratar el cáncer de cuello uterino con un potenciador de la inmunidad contra el virus de papiloma humano
CL2012002526A1 (es) Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca.
BRPI0919346A2 (pt) lente oftálmica energizada.
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
ATE404225T1 (de) Radiofluorierte peptide
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
ES2722799T3 (es) Vacunas contra el cáncer de cerebro basadas en el péptido alfa 2 del receptor de interleuquina-13
CY1115413T1 (el) Ανασυνδυασμενη fsh η οποια περιλαμβανει αλφα 2,3- και αλφα 2',6-sialylation
ES2585480T3 (es) Anticuerpo anti-NR10 y uso del mismo
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
ES2530670T3 (es) Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo
ES2551697T3 (es) Protección de péptidos contra toxicidad por luz ultravioleta
ES2527454T3 (es) El uso de derivados del péptido Wnt5-a para el tratamiento de melanoma y cáncer gástrico
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
CL2007002388A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas.
ITTO20050654A1 (it) Riporto duro per calibro di punta da trivellazione.
ES2536238T3 (es) Péptidos antimicrobianos
NL1030571A1 (nl) Geurafgiftesysteem.
NL1030597A1 (nl) Geurafgiftesysteem.
ES2605171T3 (es) Composiciones ansiolíticas que comprenden péptidos derivados de la Caseína ALFAs1